Ulisses Pharmaceuticals Private Limited

Ulisses Pharmaceuticals Private Limited - chemicals in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U24290DL2021PTC376099 Incorporated 23 January 2021 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2025
₹34.2 Lakh
▼ 7% YoY
Net loss · FY 2025
₹2.4 Lakh
Net margin -7%
EBITDA · FY 2025
-₹2.4 Lakh
EBITDA margin -7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings

About Ulisses Pharmaceuticals Private Limited

Data last updated:

Ulisses Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 23 January 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC376099.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Shashikala Upadhyay and Mahi Upadhyay.

Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 786 – A – 1 G/F Prem Nagar, Baljeet Nagar(Bnc – 0976), New Delhi, Delhi, India – 110008.

As per the financials filed for FY 2025, the company reported a revenue of ₹34.2 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹2.4 Lakh (net margin -7%) and EBITDA of -₹2.4 Lakh (EBITDA margin -7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.

The company has about 6 employees on its provident fund (EPFO) records.

Ulisses Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0006793). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290DL2021PTC376099
Registration Number 376099
Incorporation Date 23 January 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0006793

Recognitions & Rankings of Ulisses Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-UP-75-0006793

Contact details

Ulisses Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.

  • Registered Address
    T – 786 – A – 1 G/F Prem Nagar, Baljeet Nagar(Bnc – 0976), New Delhi, Delhi, India – 110008
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Ulisses Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ulisses Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Ulisses Pharmaceuticals Private Limited, buy the company report.

Financials of Ulisses Pharmaceuticals Private Limited

FY 2025 filings available

Ulisses Pharmaceuticals Private Limited reported revenue of ₹34.2 Lakh (down 7% YoY) for FY 2025.

Revenue · FY 2025
₹34.2 Lakh ▼ 7%
Net loss · FY 2025
₹2.4 Lakh margin -7%
EBITDA · FY 2025
-₹2.4 Lakh margin -7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 145%
3 years · compounded
▼ 25%

Revenue fell 7% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.4 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.4 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-7%
Net Profit Margin-7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ulisses Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ulisses Pharmaceuticals Private Limited

Ulisses Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shashikala UpadhyayDirector23 Jan 20215 Years 9 MonthsCurrent
Mahi UpadhyayDirector29 Nov 20250 Years 11 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ulisses Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Ulisses Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ulisses Pharmaceuticals Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Mahi Upadhyay was appointed as Director on 29 Nov 2025.

Appointed
Mahi Upadhyay was appointed as Director.
AGM
Ulisses Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Filing
Ulisses Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Diwaker Mishra ceased to be Director.
Ceased
Sarita Sahi ceased to be Director.
Appointed
Harishchandra Upadhyay was appointed as Director.
Appointed
Shashikala Upadhyay was appointed as Director.
Incorporation
23 Jan 2021
Ulisses Pharmaceuticals Private Limited was registered on 23 Jan 2021 with Roc Delhi Ii & aged 5 years 9 months as per MCA records.

Frequently asked questions

Ulisses Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 23 January 2021 (5+ years old) and is registered under CIN U24290DL2021PTC376099.

Ulisses Pharmaceuticals has 2 current directors:

The latest financial statements of Ulisses Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 21 August 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Ulisses Pharmaceuticals is U24290DL2021PTC376099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ulisses Pharmaceuticals was incorporated on 23 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

Mahi Upadhyay was appointed as Director on 29 Nov 2025. Diwaker Mishra ceased to be Director on 29 Dec 2022. Sarita Sahi ceased to be Director on 29 Dec 2022. Ulisses Pharmaceuticals has 5 board changes on record in total.

Yes, Ulisses Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0006793).

The registered office of Ulisses Pharmaceuticals is at T – 786 – A – 1 GF Prem Nagar, Baljeet NagarBnc – 0976, New Delhi, Delhi, India – 110008.

Ulisses Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

The compliance status of Ulisses Pharmaceuticals is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.